| PACKAGING TYPE: | 10x10 Alu-alu (10 Strips In 1 Box) |
| COMPOSITION: | Gliclazide (60mg) + Metformin (500mg) (extended Released) |
| FORMULATION: | Tablet |
| Description: | GLYZIMAC OD 60 Tablet is a combination antidiabetic medication containing: Gliclazide 60mg – a sulfonylurea that stimulates insulin secretion from pancreatic beta cells. Metformin Hydrochloride 500mg – a biguanide that reduces glucose production in the liver and improves insulin sensitivity. This combination is used for the management of Type 2 Diabetes Mellitus, offering enhanced glycemic control when monotherapy is insufficient. The formulation provides effective control of fasting and postprandial blood glucose levels, helping reduce the risk of long-term diabetic complications. |
| Side Effects: | Common side effects: Nausea or diarrhea Abdominal discomfort Headache Hypoglycemia (low blood sugar) Rare but serious side effects: Lactic acidosis (rare, due to Metformin) Severe hypoglycemia Liver or kidney function abnormalities Allergic reactions (rash, swelling, difficulty breathing) |
| How to Use: | Take GLYZIMAC OD 60 Tablet orally, usually once daily with meals or as prescribed. Swallow the tablet whole with water. Do not skip meals to prevent hypoglycemia. Maintain a healthy diet and regular exercise routine. Monitor blood glucose levels regularly. |
| Precaution: | Monitor for symptoms of hypoglycemia (sweating, dizziness, confusion). Use cautiously in patients with kidney or liver impairment. Avoid excessive alcohol consumption due to risk of lactic acidosis. Inform your doctor about all medications to avoid interactions. Not recommended during pregnancy or breastfeeding without medical advice. |
| Product Benefits: | Provides dual-action blood sugar control. Helps reduce fasting and post-meal glucose levels. Improves insulin secretion and insulin sensitivity. Reduces risk of diabetes-related complications. Suitable for once-daily (OD) dosing for better compliance. |
Frequently Asked Questions
It is used to manage Type 2 Diabetes Mellitus by controlling blood sugar levels.
Yes, it contains a higher dose of Gliclazide (60mg), making it more effective for patients needing stronger control.
Yes, due to Gliclazide, it may cause hypoglycemia, especially if meals are skipped.












